Zobrazeno 1 - 10
of 596
pro vyhledávání: '"VAERS, Vaccine adverse event reporting system"'
Autor:
Miloslav Klugar, Sameh Attia, Giordano Pérez-Gaxiola, Tina Poklepović Peričić, Janja Marc, Abanoub Riad
Sažetak nije dostupan.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4fb121a8bf2a1a5c8eaf50ac19625f6
https://www.bib.irb.hr/1279831
https://www.bib.irb.hr/1279831
Autor:
Christine M. Akamine, Hana M. El Sahly
Publikováno v:
Translational Research
The mRNA therapeutics have been studied since the 1970s and the currently available mRNA vaccines against COVID-19 are the culmination of decades of scientific research. The mRNA vaccines BNT162b2 and mRNA-1273 have played a key role in our global re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5fb17a5ba87457527cd1ba281170c15
https://pubmed.ncbi.nlm.nih.gov/34954088
https://pubmed.ncbi.nlm.nih.gov/34954088
Autor:
Paul D. Williams, Aleena Banerji, Anna R. Wolfson, Cosby A. Stone, Lacey B. Robinson, Elizabeth J. Phillips, Aidan A. Long, Kimberly G. Blumenthal, Rebecca R. Saff, David A. Khan, Paige G. Wickner
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice
The Journal of Allergy and Clinical Immunology. in Practice
The Journal of Allergy and Clinical Immunology. in Practice
The U.S. Food and Drug Administration (FDA) has recently issued an Emergency Use Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines from Pfizer-BioNTech and Moderna. This has brought hope to millions of Americans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f0b30e628164b03092dbff50d0ef0fa
Publikováno v:
Vaccine: X
Vaccine: X, Vol 10, Iss, Pp 100139-(2022)
Vaccine: X, Vol 10, Iss, Pp 100139-(2022)
The development of SARS-CoV-2 vaccines during the COVID-19 pandemic has prompted the emergence of COVID-19 vaccine data. Timely access to COVID-19 vaccine information is crucial to researchers and public. To support more comprehensive annotation, int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112be018c7260762f098b8190a7a5791
https://doi.org/10.1016/j.jvacx.2021.100139
https://doi.org/10.1016/j.jvacx.2021.100139
Autor:
Ross, E, Munoz, F M, Edem, B, Nan, C, Jehan, F, Quinn, J, Moore, TM, Sesay, S, Spiegel, H, Fortuna, L, Kochhar, Sonali, Buttery, J
Publikováno v:
Vaccine
Vaccine, 35(48), 6483-6491. Elsevier
Vaccine, 35(48), 6483-6491. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b8d9ee495ad6e386e02b1e22c6557c84
http://europepmc.org/articles/PMC5714432
http://europepmc.org/articles/PMC5714432
Autor:
Strid, Penelope, Abara, Winston E., Clark, Elizabeth, Moro, Pedro L., Olson, Christine K., Gee, Julianne
Publikováno v:
Obstetrics & Gynecology; Aug2024, Vol. 144 Issue 2, p283-287, 5p
Autor:
Judy A. Beeler, Maryna C. Eichelberger
Publikováno v:
Microbial Pathogenesis
Respiratory viral infections in infants and young children frequently cause illness that can easily progress to hospitalization and death. There are currently no licensed vaccines to prevent respiratory viral disease in children younger than 6 months
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7e2e6f88d66dc06b483cbad4d64bf27
https://doi.org/10.1016/j.micpath.2012.11.013
https://doi.org/10.1016/j.micpath.2012.11.013
Autor:
Painter, Jeffery L.1 (AUTHOR), Kassekert, Raymond2 (AUTHOR), Bate, Andrew3,4 (AUTHOR) andrew.x.bate@gsk.com
Publikováno v:
Frontiers in Drug Safety & Regulation. 2024, p1-10. 10p.
Autor:
Zwiers, Laura C.1,2 (AUTHOR) laura.zwiers@juliusclinical.com, Grobbee, Diederick E.1,2 (AUTHOR), Uijl, Alicia1,3,4 (AUTHOR), Ong, David S. Y.1,2,5 (AUTHOR)
Publikováno v:
BMC Infectious Diseases. 11/21/2024, Vol. 24 Issue 1, p1-14. 14p.
Autor:
Zhao, Bangyao, Zhao, Lili
Publikováno v:
Statistics in Medicine; 5/10/2023, Vol. 42 Issue 10, p1512-1524, 13p